These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


164 related items for PubMed ID: 28787742

  • 1. A Pilot Study Investigating Clinical Responses and Biological Pathways of Azelastine/Fluticasone in Nonallergic Vasomotor Rhinitis before and after Cold Dry Air Provocation.
    Singh U, Bernstein JA, Lorentz H, Sadoway T, Nelson V, Patel P, Salapatek AM.
    Int Arch Allergy Immunol; 2017; 173(3):153-164. PubMed ID: 28787742
    [Abstract] [Full Text] [Related]

  • 2. Provocation of nonallergic rhinitis subjects in response to simulated weather conditions using an environmental exposure chamber model.
    Bernstein JA, Salapatek AM, Lee JS, Nelson V, Wilson D, D'Angelo P, Tsitoura D, Murdoch R, Patel D.
    Allergy Asthma Proc; 2012; 33(4):333-40. PubMed ID: 22762553
    [Abstract] [Full Text] [Related]

  • 3. Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber.
    Bousquet J, Meltzer EO, Couroux P, Koltun A, Kopietz F, Munzel U, Kuhl HC, Nguyen DT, Salapatek AM, Price D.
    J Allergy Clin Immunol Pract; 2018; 6(5):1726-1732.e6. PubMed ID: 29425904
    [Abstract] [Full Text] [Related]

  • 4. Short-time cold dry air exposure: a useful diagnostic tool for nasal hyperresponsiveness.
    Van Gerven L, Boeckxstaens G, Jorissen M, Fokkens W, Hellings PW.
    Laryngoscope; 2012 Dec; 122(12):2615-20. PubMed ID: 22865676
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment.
    Berger W, Meltzer EO, Amar N, Fox AT, Just J, Muraro A, Nieto A, Valovirta E, Wickman M, Bousquet J.
    Pediatr Allergy Immunol; 2016 Mar; 27(2):126-33. PubMed ID: 26928753
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis.
    Banov CH, Lieberman P, Vasomotor Rhinitis Study Groups.
    Ann Allergy Asthma Immunol; 2001 Jan; 86(1):28-35. PubMed ID: 11206234
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vasomotor rhinitis: clinical efficacy of azelastine nasal spray in comparison with placebo.
    Gehanno P, Deschamps E, Garay E, Baehre M, Garay RP.
    ORL J Otorhinolaryngol Relat Spec; 2001 Jan; 63(2):76-81. PubMed ID: 11244365
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of intranasal azelastine on substance P release in perennial nonallergic rhinitis patients.
    Gawlik R, Jawor B, Rogala B, Parzynski S, DuBuske L.
    Am J Rhinol Allergy; 2013 Jan; 27(6):514-6. PubMed ID: 24274229
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Real-life effectiveness of MP-AzeFlu in Irish patients with persistent allergic rhinitis, assessed by visual analogue scale and endoscopy.
    Kaulsay R, Nguyen DT, Kuhl HC.
    Immun Inflamm Dis; 2018 Dec; 6(4):456-464. PubMed ID: 30306729
    [Abstract] [Full Text] [Related]

  • 15. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Denmark.
    Haahr PA, Jacobsen C, Christensen ME.
    Int Forum Allergy Rhinol; 2019 Apr; 9(4):388-395. PubMed ID: 30659752
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of nonallergic perennial rhinitis.
    Ciprandi G.
    Allergy; 2004 Apr; 59 Suppl 76():16-22; discussion 22-3. PubMed ID: 14984552
    [Abstract] [Full Text] [Related]

  • 19. Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK.
    Scadding G, Price D, El-Shanawany T, Ahmed S, Ray J, Sargur R, Kumar N.
    BMJ Open; 2017 Apr 24; 7(4):e014777. PubMed ID: 28442578
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.